Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05710757 · ClinicalTrials.gov registry record · NA
Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening
A NA study of Proximal Muscle Strength and Proximal Muscle Lengthening, sponsored by University of Tennessee.
- Active
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT05710757 is a NA study of Proximal Muscle Strength and Proximal Muscle Lengthening that is active but no longer recruiting, run by University of Tennessee. The registered enrollment target is 60 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05710757, a NA study of Proximal Muscle Strength and Proximal Muscle Lengthening, is active but no longer recruiting, sponsored by University of Tennessee.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to assess strength gains of proximal musculature in the nondominant upper extremity after implementing blood flow restriction (BFR) and myofascial release (MFR) with the supplementation of whey protein.
Conditions Studied
Interventions
- DEVICE blood flow restriction
- OTHER myofascial release
Study Locations (1)
Tennessee
- University of Tennessee Health Science Center - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-10-16 |
| Est. Completion | 2024-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05710757
The ClinicalTrials.gov registry entry for NCT05710757 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Tennessee, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Proximal Muscle Strength appearing as the primary indexed condition, and to 2 interventions - of which blood flow restriction is the first listed.
NCT05710757 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05710757 about?
NCT05710757 is a clinical study titled "Investigating Proximal Muscle Strength Effects by Incorporating Proximal Muscle Lengthening". The purpose of this study is to assess strength gains of proximal musculature in the nondominant upper extremity after implementing blood flow restriction (BFR) and myofascial release (MFR) with the supplementation of whey protein.
What is the current status of trial NCT05710757?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2023-10-16. Estimated completion is 2024-09.
What conditions does trial NCT05710757 study?
This clinical trial studies the following conditions: Proximal Muscle Strength, Proximal Muscle Lengthening.
What interventions are being tested in trial NCT05710757?
The interventions under investigation include: blood flow restriction (DEVICE), myofascial release (OTHER).
Who is sponsoring clinical trial NCT05710757?
This trial is sponsored by University of Tennessee, which has 96 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05710757 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.